RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.
about
Bioabsorbable polymers in cancer therapy: latest developmentsAn in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line.1,3-Bis(2-chloroethyl)-1-nitrosourea-loaded bovine serum albumin nanoparticles with dual magnetic resonance-fluorescence imaging for tracking of chemotherapeutic agents.The effect of superparamagnetic iron oxide with iRGD peptide on the labeling of pancreatic cancer cells in vitro: a preliminary study.In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.Current and future intraoperative imaging strategies to increase radical resection rates in pancreatic cancer surgery.Magnetic resonance-guided regional gene delivery strategy using a tumor stroma-permeable nanocarrier for pancreatic cancerBiocompatible and biodegradable fibrinogen microspheres for tumor-targeted doxorubicin delivery.Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.Targeting tumor metastases: Drug delivery mechanisms and technologies.Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line.Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Tumor Targeting via Integrin Ligands.Current and future intratumoral targeted treatment for pancreatic cancer.Albumin and its application in drug delivery.A cascade enzymatic reaction activatable gemcitabine prodrug with an AIE-based intracellular light-up apoptotic probe for in situ self-therapeutic monitoring.Co-Delivery of Docetaxel and p44/42 MAPK siRNA Using PSMA Antibody-Conjugated BSA-PEI Layer-by-Layer Nanoparticles for Prostate Cancer Target Therapy.
P2860
Q26775714-FF8264C3-A0D3-4688-8C00-41157840624EQ27336445-D6FA5E71-FF85-4261-8B01-529D4D8CB09CQ31127105-828A0C09-E41E-4AD6-B647-3E291C8DDE1BQ33746572-603CA4CA-1C5B-49CE-92F6-B30CC7E01532Q33758252-D2E01D10-E4F1-4318-BD92-B1549D29AA61Q34009539-6C481EA1-2B8E-4E3D-8F7C-4B6BFFC288EAQ35867668-6444CAEC-BD6F-45C0-A3DC-CF8ACD91E823Q36037022-78FE1F9D-8D83-423A-B2AF-70B318056618Q36185327-183B7251-4CC0-4C9D-A475-C0E3D107F91AQ36557855-6CA34071-F6F9-487F-93FF-38881A82BF8CQ37168978-C47FDA9F-AA08-4EE4-B72E-D6CAF588CA94Q38054112-619397CF-7815-49F9-806A-909762CF6A7EQ38067265-2818AA9B-EAD4-4CEA-82D9-0768F2DC5486Q38134759-0C3F0CB8-40CD-470F-9C35-9B02717DE005Q38261961-088EE37D-6BF0-462E-8BA0-B107DD9FAA9DQ38292087-B99DA58C-7105-4822-B159-D58064AA1C1FQ47854170-D81A762E-A84D-44EB-B32A-2845201549BEQ51165974-CDBB7E15-7132-44FD-8329-FF04083BFCCC
P2860
RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
RGD-conjugated albumin nanopar ...... in pancreatic cancer therapy.
@ast
RGD-conjugated albumin nanopar ...... in pancreatic cancer therapy.
@en
RGD-conjugated albumin nanopar ...... in pancreatic cancer therapy.
@nl
type
label
RGD-conjugated albumin nanopar ...... in pancreatic cancer therapy.
@ast
RGD-conjugated albumin nanopar ...... in pancreatic cancer therapy.
@en
RGD-conjugated albumin nanopar ...... in pancreatic cancer therapy.
@nl
prefLabel
RGD-conjugated albumin nanopar ...... in pancreatic cancer therapy.
@ast
RGD-conjugated albumin nanopar ...... in pancreatic cancer therapy.
@en
RGD-conjugated albumin nanopar ...... in pancreatic cancer therapy.
@nl
P2093
P2860
P356
P1476
RGD-conjugated albumin nanopar ...... in pancreatic cancer therapy.
@en
P2093
Huimin Hou
Quanxing Ni
Shunrong Ji
Wantong Yao
Xianjun Yu
P2860
P304
P356
10.4161/CBT.13.4.18692
P577
2012-02-01T00:00:00Z